Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Cash from Discontinued Operations (2020 - 2021)

Serina Therapeutics' Cash from Discontinued Operations history spans 2 years, with the latest figure at 90000.0 for Q1 2021.

  • For Q1 2021, Cash from Discontinued Operations fell 151.14% year-over-year to 90000.0; the TTM value through Dec 2021 reached 90000.0, changed N/A, while the annual FY2021 figure was 90000.0, 147.12% down from the prior year.
  • Cash from Discontinued Operations for Q1 2021 was 90000.0 at Serina Therapeutics, up from 92000.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 176000.0 in Q1 2020 and bottomed at 92000.0 in Q2 2020.